Symptomtext
ADACEL (Tdap) vaccine that was given instead of DAPTACEL (DTap) with no reported adverse event; Initial information received on 01-Sep-2023 regarding an unsolicited valid non-serious case received via other health professional. This case involves a 5-year-old female patient, diphtheria-2/tetanus/5 AC pertussis vaccine [Adacel] vaccine that was given instead of diphtheria-15/tetanus/5 AC pertussis vaccine [Daptacel] (dtap) with no reported adverse event and. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included hepatitis A vaccine for Prophylactic vaccination; and polio vaccine for Prophylactic vaccination. On an unknown date, the patient received an unknown dose of suspect diphtheria-15/tetanus/5 AC pertussis vaccine Suspension for injection (strength, lot number, expiry date: unknown) not reported via unknown route in unknown administration site for Prophylactic Vaccination (immunization). On 21-Aug-2023, the patient received dose 1 of 0.5 ml total dose of suspect diphtheria-2/tetanus/5 AC pertussis vaccine Suspension for injection (lot: U7870AB, Expiry date: 23-Aug-2023) via intramuscular route in the left thigh for for Prophylactic Vaccination (immunization) and adacel (tdap) vaccine that was given instead of daptacel (dtap) with no reported adverse event (wrong product administered) (latency: same day) Action taken with diphtheria, tetanus and acellular pertussis vaccine (Adacel) and diphtheria, tetanus and acellular pertussis vaccine (Daptacel) was not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.